ArticlePediatric transplantation2026
Central Nervous System Infections in Pediatric Solid Organ Transplant Recipients.
Article in Pediatric transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSolid organ transplant (SOT) recipients face an increased risk of central nervous system (CNS) infections due to immunosuppression. The incidence of CNS infections in adult SOT recipients ranges from 0.4% to 10%, while it remains unknown in pediatric SOT recipients. Herein, we describe the incidence, clinical presentation, and outcomes of CNS infections in pediatric SOT recipients.
methodsWe conducted a single-center retrospective cohort study that included 1628 first-time SOT recipients ≤ 21 years of age from 2003 to 2023.
resultsWe identified 23 patients with CNS infection representing an incidence of 2.3 per 1000 patient-years. They occurred in 8/400 (2%) heart; 7/570 (1.2%) liver; 5/220 (2.3%) lung; 2/400 (0.5%) kidney, and 1/38 (2.6%) multi-organ transplant recipients. Documented symptoms included fever in 15/23 (65%), altered mental status in 7/23 (30%), nausea and emesis in 6/23 (26%), and headache in 6/23 (26%). Neuroimaging was performed in 15/23 (65%) patients with CNS infection; 10/15 (67%) had abnormal findings. Bacterial and fungal infections predominated, each accounting for 8/23 (35%) cases, followed by viral infections in 7/23 (30%) cases. Among patients with CNS infection, all-cause mortality was observed in 9/23 (39%), while it was 263/1605 (16%) in those without a CNS infection (p < 0.01).
conclusionsCNS infections in SOT recipients are rare and presentation can be non-specific, though associated with a high mortality. These findings highlight the importance of maintaining clinical awareness of CNS infection in SOT recipients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.